| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/29/2002 | CA2194555C Implanted device containing tumor cells for the treatment of cancer |
| 01/29/2002 | CA2010776C Zn-, cu-, and mn-lactoferrins for promoting proliferation of useful microorganisms and suppressing proliferation of harmful microorganisms |
| 01/29/2002 | CA1341336C Neuropeptide y agonists |
| 01/28/2002 | CA2352645A1 Compositions for dna transfection |
| 01/27/2002 | CA2353768A1 Use of growth hormone secretagogues for improvement of functional health status |
| 01/24/2002 | WO2002006821A2 Antimicrobial agent |
| 01/24/2002 | WO2002006633A1 Remote control for a drilling machine |
| 01/24/2002 | WO2002006630A1 Apparatus and method for maintaining control of a drilling machine |
| 01/24/2002 | WO2002006515A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 01/24/2002 | WO2002006492A1 A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction |
| 01/24/2002 | WO2002006489A1 A novel polypeptide, a human cytochrome c oxidase subunit 8.91 and the polynucleotide encoding the polypeptide |
| 01/24/2002 | WO2002006488A1 A NOVEL POLYPEPTIDE, A HUMAN DNA POLYMERASE δ 12.65 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE |
| 01/24/2002 | WO2002006483A1 Novel physiologically active peptide and use thereof |
| 01/24/2002 | WO2002006482A1 Receptor protein specifically recognizing bacterial dna |
| 01/24/2002 | WO2002006481A1 Target of anticancer agent |
| 01/24/2002 | WO2002006480A2 Tissue inhibitors of matrix metalloproteinases |
| 01/24/2002 | WO2002006479A2 Apoptosis-inducing dna sequences |
| 01/24/2002 | WO2002006478A2 Extracellular matrix protein |
| 01/24/2002 | WO2002006477A1 A novel polypeptide-homo topoisomerase 12.1 and polynucleotide encoding said polypeptide |
| 01/24/2002 | WO2002006476A1 A novel polypeptide, a human cytokine receptor 10.67 and the polynucleotide encoding the polypeptide |
| 01/24/2002 | WO2002006474A1 A novel polypeptide, a human ehd protein 12.1 and the polynucleotide encoding the polypeptide |
| 01/24/2002 | WO2002006473A1 A novel polypeptide, a human estrogen receptor relative protein 10.01 and the polynucleotide encoding the polypeptide |
| 01/24/2002 | WO2002006470A1 A novel polypeptide, a human myoglobulin ixa11.88 and the polynucleotide encoding the polypeptide |
| 01/24/2002 | WO2002006462A2 Methylated nucleotide regulation of upa gene expression |
| 01/24/2002 | WO2002006460A2 Masp-2, a complement-fixing enzyme, and uses for it |
| 01/24/2002 | WO2002006457A2 Novel lipase genes |
| 01/24/2002 | WO2002006454A2 Regulation of human carboxylesterase-like enzyme |
| 01/24/2002 | WO2002006453A2 Regulation of human desc1-like serine protease |
| 01/24/2002 | WO2002006344A2 Rtvp based compositions and methods for the treatment of prostate cancer |
| 01/24/2002 | WO2002006343A2 Composition for treatment of and method of monitoring hepatitis c virus using interferon-tau |
| 01/24/2002 | WO2002006342A2 G-protein coupled receptors and nucleic acids encoding same |
| 01/24/2002 | WO2002006341A1 A trophic factor capable of producing a neurosalutary effect in a subject |
| 01/24/2002 | WO2002006340A2 Tetraspan protein and uses thereof |
| 01/24/2002 | WO2002006338A1 Vaccine comprising a lung tumour associated antigen |
| 01/24/2002 | WO2002006337A1 A novel polypeptide - human hydroxyindole-o-methyl-transferase 12.43 and a polynucleotide encoding the same |
| 01/24/2002 | WO2002006332A1 A new polypeptide- human fk506 binding protein 13.42 and the polynucleotide encoding it |
| 01/24/2002 | WO2002006329A2 Human polynucleotides and polypeptides encoded thereby |
| 01/24/2002 | WO2002006327A2 A method for prognosing cancer and the proteins involved |
| 01/24/2002 | WO2002006324A2 Antifungal and/or antibacterial peptides, preparation methods and composition containing same |
| 01/24/2002 | WO2002006323A1 IMMUNOGENIC PROTEINS DERIVED FROM DOMESTIC MITE ALLERGEN, BLOMIA TROPICALIS (Bt5) |
| 01/24/2002 | WO2002006318A2 Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells |
| 01/24/2002 | WO2002006317A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 01/24/2002 | WO2002006316A2 Alpha-msh related compounds and methods of use |
| 01/24/2002 | WO2002006315A2 Novel nucleic acid and amino acid sequences |
| 01/24/2002 | WO2002006313A2 Regulation of human glutamate receptor delta-1 subunit |
| 01/24/2002 | WO2002006312A2 Disease-associated gene |
| 01/24/2002 | WO2002006308A2 Methods for promoting dendritic cell proliferation or differentiation |
| 01/24/2002 | WO2002006307A1 Reduced fk228 and use thereof |
| 01/24/2002 | WO2002006301A2 Peptides with antioxidant and antimicrobial properties |
| 01/24/2002 | WO2002006300A2 Mutated pf-4, its fragments and mutated fusion peptides, their analogues, corresponding dna, cdna and mrna sequences and their use for inhibiting angiogenesis |
| 01/24/2002 | WO2002006297A1 Novel antisense oligonucleotide derivatives against wilms's tumor gene |
| 01/24/2002 | WO2002006292A1 Phosphate esters of bis-amino acid sulfonamides containing substituted benzyl amines |
| 01/24/2002 | WO2002006227A1 Matrix metalloprotease inhibitors |
| 01/24/2002 | WO2002006190A2 Crystalline and salt forms of an hiv protease inhibitor |
| 01/24/2002 | WO2002005944A1 Method for encapsulating fine solid particles in the form of microcapsules |
| 01/24/2002 | WO2002005864A1 An implantable or insertable therapeutic agent delivery device |
| 01/24/2002 | WO2002005857A2 Phosphatonin-related gene and methods of use thereof |
| 01/24/2002 | WO2002005854A2 Bridged glycoconjugates |
| 01/24/2002 | WO2002005844A2 Protein complex serving as a vehicle for orally administerable medicaments |
| 01/24/2002 | WO2002005843A2 Human rrp sequences and methods of use |
| 01/24/2002 | WO2002005842A2 Preventing airway mucus production by administration of egf-r antagonists |
| 01/24/2002 | WO2002005841A1 Treatment of glycogen storage disease type ii |
| 01/24/2002 | WO2002005840A1 Medicinal compositions for promoting fixation of transplanted cells |
| 01/24/2002 | WO2002005839A1 Agent for inhibiting adhesion of the pathogenic flora of the skin |
| 01/24/2002 | WO2002005838A1 Derivatives of laspartomycin and preparation and use thereof |
| 01/24/2002 | WO2002005837A1 Antimicrobial sulfonamide derivatives of lipopeptide antibiotics |
| 01/24/2002 | WO2002005836A2 Stimulation of bone growth with thrombin peptide derivatives |
| 01/24/2002 | WO2002005835A2 Modulation of apoptosis |
| 01/24/2002 | WO2002005834A2 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions |
| 01/24/2002 | WO2002005833A1 MANNAN-BINDING LECTIN (MBL) TREATMENT OF INFECTIONS IN INDIVIDUALS TREATED WITH TNF-αinhibitors |
| 01/24/2002 | WO2002005828A1 Compositions and methods for the treatment of skin damage |
| 01/24/2002 | WO2002005827A2 Use of natural products in cancer treatment |
| 01/24/2002 | WO2002005810A1 Modulation of nitric oxide synthase by pkc |
| 01/24/2002 | WO2002005792A2 Use of matrix metalloprotease inhibitors for the treatment of cancer |
| 01/24/2002 | WO2002005773A1 Topical treatment of skin |
| 01/24/2002 | WO2002005749A2 Crf2 ligands in combination therapy |
| 01/24/2002 | WO2002005748A2 Medicinal uses of mu-opioid receptor agonists |
| 01/24/2002 | WO2001085215A9 METHODS OF MODULATING FUNCTIONS OF POLYPEPTIDE GalNAc TRANSFERASES AND OF SCREENING SUBSTANCES THEREFOR, PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH AGENTS |
| 01/24/2002 | WO2001082872A3 A medicinal aerosol formulation |
| 01/24/2002 | WO2001078761A3 Mixture of defibrotide and g-csf ant its use for activating haematopoietic progenitors |
| 01/24/2002 | WO2001077152A3 Mammalian disulfide core protein-4 |
| 01/24/2002 | WO2001075018A3 A novel polypeptide, a human regulation factor of transcription 31 and the polynucleotide encoding the polypeptide |
| 01/24/2002 | WO2001070767A3 Therapeutic anti-melanoma compounds |
| 01/24/2002 | WO2001068681A3 Altered ion channel proteins |
| 01/24/2002 | WO2001066132A3 Hiv immune adjuvant therapy |
| 01/24/2002 | WO2001064750A3 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 01/24/2002 | WO2001060794A3 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 01/24/2002 | WO2001060351A3 Nitroacridine/tumor inhibitor compositions |
| 01/24/2002 | WO2001059115A3 83p5g4: a tissue specific protein highly expressed in prostate cancer |
| 01/24/2002 | WO2001056405A3 A method for maintaining or improving the synthesis of mucins |
| 01/24/2002 | WO2001055324A3 Nucleic acids, proteins, and antibodies |
| 01/24/2002 | WO2001055212A3 Delivery of therapeutic biological from implantable tissue matrices |
| 01/24/2002 | WO2001054706A3 Method for treating kidney disorders |
| 01/24/2002 | WO2001053324A3 Novel haptotactic peptides |
| 01/24/2002 | WO2001052892A3 Jak/stat pathway inhibitors and the uses thereof |
| 01/24/2002 | WO2001052878A3 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 01/24/2002 | WO2001051071A3 Transepithelial delivery of glp-1 derivatives |
| 01/24/2002 | WO2001046258A3 Transporters and ion channels |
| 01/24/2002 | WO2001044286A3 Five-helix protein |
| 01/24/2002 | WO2001042465A3 Chordin-like molecules and uses thereof |